GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,925,000 | +47.6% | 365,875 | +47.7% | 0.08% | +63.5% |
| Q1 2022 | $10,792,000 | +4.0% | 247,754 | +5.3% | 0.05% | +8.3% |
| Q4 2021 | $10,379,000 | +28.6% | 235,377 | +11.4% | 0.05% | +14.3% |
| Q3 2021 | $8,073,000 | +7.2% | 211,308 | +11.7% | 0.04% | 0.0% |
| Q2 2021 | $7,531,000 | +56.7% | 189,130 | +40.4% | 0.04% | +27.3% |
| Q1 2021 | $4,805,000 | +5.7% | 134,667 | +9.0% | 0.03% | -2.9% |
| Q4 2020 | $4,546,000 | -95.7% | 123,587 | -95.6% | 0.03% | -96.6% |
| Q3 2020 | $105,786,000 | -8.1% | 2,810,528 | -0.4% | 0.99% | -17.7% |
| Q2 2020 | $115,094,000 | -20.5% | 2,821,629 | -26.1% | 1.20% | -36.6% |
| Q1 2020 | $144,716,000 | +12195.3% | 3,819,379 | +15141.5% | 1.90% | +12553.3% |
| Q4 2019 | $1,177,000 | +14.4% | 25,059 | +3.9% | 0.02% | +7.1% |
| Q3 2019 | $1,029,000 | +13.8% | 24,126 | +6.8% | 0.01% | +7.7% |
| Q2 2019 | $904,000 | +142.4% | 22,590 | +152.8% | 0.01% | +160.0% |
| Q1 2019 | $373,000 | – | 8,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |